Topical Pain Relief Market Report 2028: Analysis of Market Size, CAGR, Profitable Segments, and Leading Regions

The latest report by MarkNtel Advisors, titled “Topical Pain Relief Market Report By Type (Prescription Pain Relief, Over-The-Counter Pain Relief), By Therapeutic Class (Non-Opioids [Nonsteroidal Anti-Inflammatory Drug, Methyl Salicylate, Capsaicin, Lidocaine], Opioids [Buprenorphine and Fentanyl]), By Formulation (Cream, Gel, Spray, Patch), By Distribution Channel (Pharmacy Drug Store, E-Commerce, Others) other and Region 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on the Topical Pain Relief Market research report.

What is the market outlook for Topical Pain Relief?
The Global Topical Pain Relief Market was valued at USD 9.5 Billion 2022 and is projected to grow at a CAGR of around 7.5% during the forecast period, i.e., 2023-28.

For an in-depth analysis, you can request a sample copy of the report:

Major Companies Operating in the Topical Pain Relief Industry:
AdvaCare Pharma, GlaxoSmithKline plc., Sanofi, Johnson & Johnson, Novartis AG, Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Topical BioMedics, Inc. (Topricin), Exzell Pharma, Emami Group

Topical Pain Relief Market Report Segmentation:
By Type

-Prescription Pain Relief

-Over-The-Counter Pain Relief

By Therapeutic Class


–Nonsteroidal Anti-Inflammatory Drug

–Methyl Salicylate






Here, the Non-opioids therapeutic class accounted for the highest market share in the historic period and is expected to maintain its status throughout the forecasting period.
By Formulation





By Distribution Channel

-Pharmacy Drug Store



Learn More About the Market Report –

Regional Insights:
North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain, The Netherlands, Norway
Asia-Pacific: China, India, Japan, South Korea, Australia, New Zealand
South America: Brazil, and Argentina
Middle East & Africa: UAE, Saudi Arabia, South Africa, Turkey
Key Driver: Growing Prevalence of Arthritis, Chronic Disease, And Diabetic Neuropathy

There has been a significant rise in arthritis, other bone-related conditions, and also diabetic neuropathy among people, which is driving the adoption of topical therapeutics, thus acting as the key driver of the topical pain relief market. With the increasing number of people with joint pain problems, especially as the older generation population is increasing, the market is likely to expand further. Also, topical therapeutics provide instant comfort to people with injuries. So, the perpetual amount of accidents in the daily life of people also in various industries is likely to fuel the market growth.

Ask Analyst for Customization:

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Reach us:
Call: +1 628 895 8081, +91 120 4278433


Visit to know more:

Topical Pain Relief Market Report 2028: Analysis of Market Size, CAGR, Profitable Segments, and Leading Regions